Nucleotrace
PrivateLast Round
Grant
Oct 10, 2017
Total Funding Raised
$2,000
Company Overview
Nucleotrace is a healthcare technology company that develops DNA-based tracing and identification technology for pharmaceutical supply chain monitoring and product authentication.
Sector
Frontier & Industrial Tech
Verticals
Supply Chain Tracking, Biotechnology, Pharma Supply Chain, Defense Tech
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nucleotrace Comparables
Compare Nucleotrace with similar companies based on industry and business-model similarity.
No public comparables are available for Nucleotrace. Request access to learn about comparables coverage.
Request accessNucleotrace Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 10, 2017 |
Nucleotrace Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cicada Innovations | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 10, 2017
$2K raised from Cicada Innovations.
Nucleotrace Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nucleotrace's valuation, stock price, and market status.
Is Nucleotrace a public or private company?
Nucleotrace is a private company.
What is the current stock price of Nucleotrace?
Nucleotrace is a private company with no public stock price. Caplight tracks Nucleotrace's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Nucleotrace worth (valuation)?
Valuation information for Nucleotrace is not publicly available.
Can I buy Nucleotrace stock?
Nucleotrace shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nucleotrace's last funding round?
Nucleotrace's most recent funding round was Grant on October 10, 2017.
Who are the main investors in Nucleotrace?
Key investors in Nucleotrace include Cicada Innovations.
Will Nucleotrace IPO soon?
No public IPO plans have been announced for Nucleotrace.
How can I track Nucleotrace secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nucleotrace's secondary market activity and sign up for updates.